Page 52 - பாஷ் ஆரோக்கியம் நிறுவனங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Generic Drugs Market Revenue Worth $786 Billion by 2030 says P&S Intelligence NEW YORK, March 17, 2021 /PRNewswire/ Almost 75% of the deaths in 2020 were because of chronic diseases, as per the World Health Organization (WHO). Among the diseases, the deadliest were ischemic heart disease, diabetes, cancer, and stroke. This is to be a major factor to propel the global generic drugs market size to $786.0 billion by 2030 from $278.4 billion in 2019, at a 10.0% CAGR between 2020 and 2030. This is because branded drugs are often expensive, which is why a large number of people in developing countries are not able to purchase them. Generic drugs, on the other hand, are cost-effective, at the same time contain the same active ingredients and have a similar effect as patented drugs. In this regard, the generic drugs market is also being driven by the patent expiry of blockbuster medications. As patented drugs lose their certification, it gives pharmaceutical companies the opportunity to

Prajneesh kumarKostenloser wertpapierhandelCipla ltdRoute of administration oralSawai pharmaceutical coPfizer incCadila healthcare ltdBausch health companies incTorrent pharmaceuticals ltdGlenmark life sciencesAlkem laboratoriesAmphastar pharmaceuticals incWorld health organizationGeneric drugs market researchAmneal pharmaceuticals incTaro pharmaceutical industries ltd